This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Your saved search

Name of saved search:

Search terms:

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004 Apr;53(4):262.

No authors listed

Comment

No authors listed. J Fam Pract. 2004 Apr.

. 2004 Apr;53(4):262.

No abstract available

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.
Olsson SB; Executive Steering Committee of the SPORTIF III Investigators. Olsson SB, et al. Lancet. 2003 Nov 22;362(9397):1691-8. doi: 10.1016/s0140-6736(03)14841-6. Lancet. 2003. PMID: 14643116 Clinical Trial.